Background. Congenital cytomegalovirus (CMV) infection affects∼ 1% of live births in the
US. Ten percent of these infants have symptoms at birth and another 10 to 15% acquire …

Congenital cytomegalovirus infection is the most common cause of nonhereditary
sensorineural hearing loss and an important cause of psychomotor retardation. Earlier …

Background: Congenital cytomegalovirus (CMV) infection is common, and its morbidity rate
is high. Ganciclovir (GCV) treatment has been used for congenital CMV infection, but there …

Congenital cytomegalovirus (CMV) infection occurs in∼ 1% of newborns in the United
States. A phase II evaluation was done of ganciclovir for the treatment of symptomatic …

The efficacy of two regimens of ganciclovir therapy was evaluated in 12 infants with
symptomatic congenital cytomegalovirus (CMV) infection. Virologic investigations included …

Objective The objective of this study is to look for evidence based or scientific guidelines for
selection of newborns with congenital cytomegalovirus (CMV) infection that might benefit …

Background Long-term hearing outcomes among children with symptomatic congenital
cytomegalovirus (CMV) disease who received 6-week ganciclovir therapy early in life are …

Congenital infection caused by human cytomegalovirus (CMV) is a common occurrence, but
its significance is underappreciated. In the developed world, congenital CMV infection …

BACKGROUND: Ganciclovir protects against hearing deterioration in infants with
symptomatic congenital cytomegalovirus (CMV) disease involving the central nervous …

Congenital cytomegalovirus (CMV) infection can cause significant neurologic morbidity.
Studies have shown that antiviral therapy with ganciclovir (GCV) or valganciclovir (V-GCV) …